{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:17:07Z","timestamp":1775042227318,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Hospital","award":["KF24"],"award-info":[{"award-number":["KF24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04194-w","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:47:11Z","timestamp":1772077631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning for predicting high axillary nodal burden in breast cancer patients with positive sentinel lymph nodes"],"prefix":"10.1186","volume":"24","author":[{"given":"ShuaiKang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiansong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"4","key":"4194_CR1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"\u00c1 S\u00e1volt","year":"2017","unstructured":"S\u00e1volt \u00c1, Peley G, Csaba P, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the Axilla - Surgery or radiotherapy after positive Sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43(4):672\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2016.12.011.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"4194_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03292-2","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31(4):1154\u201362. https:\/\/doi.org\/10.1038\/s41591-025-03292-2.","journal-title":"Nat Med"},{"issue":"12","key":"4194_CR3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jamasurg.2024.3036","volume":"159","author":"I Scarping","year":"2024","unstructured":"Scarping I, Bendahl PO, Szulkin R, et al. Prediction of high nodal burden in patients with Sentinel Node\u2013Positive luminal ERBB2-Negative breast cancer. JAMA Surg. 2024;159(12):1393\u2013401. https:\/\/doi.org\/10.1001\/jamasurg.2024.3036.","journal-title":"JAMA Surg"},{"issue":"10","key":"4194_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and Sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA"},{"issue":"4","key":"4194_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u2009\u2013\u200901): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297\u2013305. https:\/\/doi.org\/10.1016\/S1470-2045(13)70035-4.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4194_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12957-021-02473-2","volume":"20","author":"T Murata","year":"2022","unstructured":"Murata T, Watase C, Shiino S, et al. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive Sentinel lymph nodes: a retrospective study. World J Surg Oncol. 2022;20(1):2. https:\/\/doi.org\/10.1186\/s12957-021-02473-2.","journal-title":"World J Surg Oncol"},{"issue":"9935","key":"4194_CR7","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists\u2019 Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8.","journal-title":"Lancet"},{"issue":"9","key":"4194_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1200\/JCO.23.02192","volume":"42","author":"P Rastogi","year":"2024","unstructured":"Rastogi P, O\u2019Shaughnessy J, Martin M, et al. Adjuvant abemaciclib plus endocrine therapy for hormone receptor\u2013Positive, human epidermal growth factor receptor 2\u2013Negative, High-Risk early breast cancer: results from a Preplanned monarche overall survival interim Analysis, including 5-Year efficacy outcomes. J Clin Oncol. 2024;42(9):987\u201393. https:\/\/doi.org\/10.1200\/JCO.23.02192.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4194_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, et al. 70-Gene signature as an aid to treatment decisions in Early-Stage breast cancer. N Engl J Med. 2016;375(8):717\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1602253.","journal-title":"N Engl J Med"},{"key":"4194_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.breast.2020.07.009","volume":"53","author":"Z Yang","year":"2020","unstructured":"Yang Z, Lan X, Huang Z, et al. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive Sentinel lymph nodes. Breast. 2020;53:143\u201351. https:\/\/doi.org\/10.1016\/j.breast.2020.07.009.","journal-title":"Breast"},{"issue":"3","key":"4194_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10549-021-06309-1","volume":"189","author":"YH Park","year":"2021","unstructured":"Park YH, Karantza V, Calhoun SR, et al. Prevalence, treatment patterns, and prognosis of low Estrogen receptor-positive (1% to 10%) breast cancer: a single institution\u2019s experience in Korea. Breast Cancer Res Treat. 2021;189(3):653\u201363. https:\/\/doi.org\/10.1007\/s10549-021-06309-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"31","key":"4194_CR12","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond MEH, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical Oncology\/College of American pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997\u20134013. https:\/\/doi.org\/10.1200\/JCO.2013.50.9984.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4194_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/annonc\/mdv259","volume":"26","author":"M Ignatiadis","year":"2015","unstructured":"Ignatiadis M, Buyse M, Sotiriou C. St Gallen international expert consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists. Ann Oncol. 2015;26(8):1519\u201320. https:\/\/doi.org\/10.1093\/annonc\/mdv259.","journal-title":"Ann Oncol"},{"issue":"19","key":"4194_CR14","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1158\/1078-0432.CCR-12-3327","volume":"19","author":"A Gucalp","year":"2013","unstructured":"Gucalp A, Tolaney S, Isakoff SJ, et al. Phase II trial of bicalutamide in patients with androgen receptor-positive, Estrogen receptor-negative metastatic breast cancer. Clin Cancer Res. 2013;19(19):5505\u201312. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3327.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 2","key":"4194_CR15","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/modpathol.2008.34","volume":"21","author":"AM Gown","year":"2008","unstructured":"Gown AM. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol. 2008;21(Suppl 2):S8\u201315. https:\/\/doi.org\/10.1038\/modpathol.2008.34.","journal-title":"Mod Pathol"},{"issue":"20","key":"4194_CR16","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical Oncology\/College of American pathologists clinical practice guideline focused update. J Clin Oncol. 2018;36(20):2105\u201322. https:\/\/doi.org\/10.1200\/JCO.2018.77.8738.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4194_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2214\/AJR.18.19996","volume":"212","author":"G Hehman","year":"2019","unstructured":"Hehman G, Koch HK, Rah CH, et al. Peering into the black box of artificial intelligence: evaluation metrics of machine learning methods. AJR Am J Roentgenol. 2019;212(1):38\u201343. https:\/\/doi.org\/10.2214\/AJR.18.19996.","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"4194_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","volume":"2","author":"SM Lundberg","year":"2018","unstructured":"Lundberg SM, Nair B, Vavilala MS, et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng. 2018;2(10):749\u201360. https:\/\/doi.org\/10.1038\/s41551-018-0304-0.","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"4194_CR19","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1245\/s10434-022-11838-0","volume":"29","author":"C Tinterri","year":"2022","unstructured":"Tinterri C, Gentile D, Gatzemeier W, et al. Preservation of axillary lymph nodes compared with complete dissection in T1-2 breast cancer patients presenting one or two metastatic Sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial. Ann Surg Oncol. 2022;29(9):5732\u201344. https:\/\/doi.org\/10.1245\/s10434-022-11838-0.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"4194_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1470-2045(25)00367-9","volume":"26","author":"AM Kaur","year":"2025","unstructured":"Kaur AM, Fairchild L, Glaser CL, et al. Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 2025;26(7):898\u2013910. https:\/\/doi.org\/10.1016\/S1470-2045(25)00367-9.","journal-title":"Lancet Oncol"},{"key":"4194_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2105-7-3","volume":"7","author":"R D\u00edaz-Uriarte","year":"2006","unstructured":"D\u00edaz-Uriarte R, Alvarez de Andr\u00e9s S. Gene selection and classification of microarray data using random forest. BMC Bioinformatics. 2006;7:3. https:\/\/doi.org\/10.1186\/1471-2105-7-3.","journal-title":"BMC Bioinformatics"},{"key":"4194_CR22","doi-asserted-by":"publisher","first-page":"102929","DOI":"10.1016\/j.tice.2025.102929","volume":"95","author":"A Bhardwaj","year":"2025","unstructured":"Bhardwaj A, Jain A. A systematic review of machine learning algorithms for breast cancer detection. Tissue Cell. 2025;95:102929. https:\/\/doi.org\/10.1016\/j.tice.2025.102929.","journal-title":"Tissue Cell"},{"key":"4194_CR23","doi-asserted-by":"publisher","first-page":"106767","DOI":"10.1016\/j.neunet.2024.106767","volume":"181","author":"A Kumar","year":"2025","unstructured":"Kumar A, Agarwal M, Singh R, et al. Support matrix machine: A review. Neural Netw. 2025;181:106767. https:\/\/doi.org\/10.1016\/j.neunet.2024.106767.","journal-title":"Neural Netw"},{"key":"4194_CR24","doi-asserted-by":"publisher","first-page":"7150304","DOI":"10.1155\/2022\/7150304","volume":"2022","author":"H Chen","year":"2022","unstructured":"Chen H, Mao X, Ma X, et al. Correlation analysis of pathological features and axillary lymph node metastasis in patients with invasive breast cancer. J Immunol Res. 2022;2022:7150304. https:\/\/doi.org\/10.1155\/2022\/7150304.","journal-title":"J Immunol Res"},{"issue":"7","key":"4194_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"361","author":"M de Boer","year":"2009","unstructured":"de Boer M, van Deurzen CHM, van Dijck JAAM, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009;361(7):653\u201363. https:\/\/doi.org\/10.1056\/NEJMoa0904832.","journal-title":"N Engl J Med"},{"key":"4194_CR26","doi-asserted-by":"publisher","first-page":"1096589","DOI":"10.3389\/fonc.2023.1096589","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, Yang P, Guo C, et al. Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients: A retrospective analysis. Front Oncol. 2023;13:1096589. https:\/\/doi.org\/10.3389\/fonc.2023.1096589.","journal-title":"Front Oncol"},{"issue":"1","key":"4194_CR27","doi-asserted-by":"publisher","first-page":"12976","DOI":"10.1038\/s41598-024-63855-6","volume":"14","author":"L Yang","year":"2024","unstructured":"Yang L, Zhao X, Yang L, et al. A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive Sentinel lymph nodes. Sci Rep. 2024;14(1):12976. https:\/\/doi.org\/10.1038\/s41598-024-63855-6.","journal-title":"Sci Rep"},{"key":"4194_CR28","doi-asserted-by":"publisher","first-page":"0346","DOI":"10.34133\/research.0346","volume":"7","author":"X Ma","year":"2024","unstructured":"Ma X, Tang X, Pan H, et al. B cells and IL-21-Producing follicular helper T cells cooperate to determine the dynamic alterations of premetastatic tumor draining lymph nodes of breast Cancer. Res (Wash D C). 2024;7:0346. https:\/\/doi.org\/10.34133\/research.0346.","journal-title":"Res (Wash D C)"},{"issue":"3","key":"4194_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10549-013-2492-3","volume":"138","author":"TJ Meretoja","year":"2013","unstructured":"Meretoja TJ, Aud RA, Heikkila PS, et al. International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with Sentinel node macrometastases. Breast Cancer Res Treat. 2013;138(3):817\u201327. https:\/\/doi.org\/10.1007\/s10549-013-2492-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"4194_CR30","doi-asserted-by":"publisher","first-page":"e21721","DOI":"10.1097\/MD.0000000000021721","volume":"99","author":"F Corsi","year":"2020","unstructured":"Corsi F, Sorrentino L, Sartani A, et al. Prediction of nodal staging in breast cancer patients with 1\u20132 Sentinel nodes in the Z0011 era. Med (Baltim). 2020;99(24):e21721. https:\/\/doi.org\/10.1097\/MD.0000000000021721.","journal-title":"Med (Baltim)"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04194-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:33:36Z","timestamp":1775036016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04194-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4194"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04194-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this retrospective study was obtained from the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University (2025-SR-653). In compliance with institutional and regulatory requirements, the need for obtaining informed consent was formally waived by the committee. The research was conducted in accordance with the ethical standards set forth in the declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}